1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Description of patients with absent/discontinued dual-antiplatelet treatment
DAPT Not Initiated at Day 1 or Discontinued Thereafter (n = 22) Antiplatelet regimen Never received DAPT (No) (%) 9/22 (40.9%) Patient days without antiplatelet treatment 71 Patient days with single antiplatelet treatment 355 Discontinued DAPT (No) (%) 13/22 (59.1%) Duration without DAPT (median) (IQR) (day) 9 (5–12) Patient days without antiplatelet treatment 17 Patient days with single antiplatelet treatment 116 Total Patient days without antiplatelet treatment 88 Patient days with single antiplatelet treatment 471 Reason for avoiding DAPT (No) (%) Hemorrhagic transformation of ischemic stroke 15 (68.1%) Subarachnoid hemorrhage 2 (9.1%) Decompressive craniectomy 3 (13.6%) Gastrointestinal bleedinga 2 (9.1%) Planned interventional/surgical procedureb 2 (9.1%) Lack of naso-/orogastric access 1 (4.5%) Duration of stent patency follow-up (median) (IQR) (day) 57 (35–125) Stent occlusion beyond day 1 (No) (%) 0 (0%)